132 related articles for article (PubMed ID: 15695371)
1. Unmodified prolactin (PRL) and S179D PRL-initiated bioluminescence resonance energy transfer between homo- and hetero-pairs of long and short human PRL receptors in living human cells.
Tan D; Johnson DA; Wu W; Zeng L; Chen YH; Chen WY; Vonderhaar BK; Walker AM
Mol Endocrinol; 2005 May; 19(5):1291-303. PubMed ID: 15695371
[TBL] [Abstract][Full Text] [Related]
2. Short form 1b human prolactin receptor down-regulates expression of the long form.
Tan D; Walker AM
J Mol Endocrinol; 2010 Mar; 44(3):187-94. PubMed ID: 19906835
[TBL] [Abstract][Full Text] [Related]
3. S179D prolactin increases vitamin D receptor and p21 through up-regulation of short 1b prolactin receptor in human prostate cancer cells.
Wu W; Ginsburg E; Vonderhaar BK; Walker AM
Cancer Res; 2005 Aug; 65(16):7509-15. PubMed ID: 16103106
[TBL] [Abstract][Full Text] [Related]
4. Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways.
Wu W; Coss D; Lorenson MY; Kuo CB; Xu X; Walker AM
Biochemistry; 2003 Jun; 42(24):7561-70. PubMed ID: 12809512
[TBL] [Abstract][Full Text] [Related]
5. Ligand-independent homo- and heterodimerization of human prolactin receptor variants: inhibitory action of the short forms by heterodimerization.
Qazi AM; Tsai-Morris CH; Dufau ML
Mol Endocrinol; 2006 Aug; 20(8):1912-23. PubMed ID: 16556730
[TBL] [Abstract][Full Text] [Related]
6. S2 deletion variants of human PRL receptors demonstrate that extracellular domain conformation can alter conformation of the intracellular signaling domain.
Tan D; Huang KT; Ueda E; Walker AM
Biochemistry; 2008 Jan; 47(1):479-89. PubMed ID: 18081308
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing to exon 11 of human prolactin receptor gene results in multiple isoforms including a secreted prolactin-binding protein.
Trott JF; Hovey RC; Koduri S; Vonderhaar BK
J Mol Endocrinol; 2003 Feb; 30(1):31-47. PubMed ID: 12580759
[TBL] [Abstract][Full Text] [Related]
8. Pseudophosphorylated prolactin (S179D PRL) inhibits growth and promotes beta-casein gene expression in the rat mammary gland.
Kuo CB; Wu W; Xu X; Yang L; Chen C; Coss D; Birdsall B; Nasseri D; Walker AM
Cell Tissue Res; 2002 Sep; 309(3):429-37. PubMed ID: 12195299
[TBL] [Abstract][Full Text] [Related]
9. Internalization of prolactin receptor and prolactin in transfected cells does not involve nuclear translocation.
Perrot-Applanat M; Gualillo O; Buteau H; Edery M; Kelly PA
J Cell Sci; 1997 May; 110 ( Pt 9)():1123-32. PubMed ID: 9175708
[TBL] [Abstract][Full Text] [Related]
10. Prolactin increases survival and migration of ovarian cancer cells: importance of prolactin receptor type and therapeutic potential of S179D and G129R receptor antagonists.
Tan D; Chen KE; Khoo T; Walker AM
Cancer Lett; 2011 Nov; 310(1):101-8. PubMed ID: 21775057
[TBL] [Abstract][Full Text] [Related]
11. S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonist.
Bernichtein S; Kinet S; Jeay S; Llovera M; Madern D; Martial JA; Kelly PA; Goffin V
Endocrinology; 2001 Sep; 142(9):3950-63. PubMed ID: 11517174
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of prolactin (PRL)-induced proliferative signals in breast cancer cells by a molecular mimic of phosphorylated PRL, S179D-PRL.
Schroeder MD; Brockman JL; Walker AM; Schuler LA
Endocrinology; 2003 Dec; 144(12):5300-7. PubMed ID: 12970160
[TBL] [Abstract][Full Text] [Related]
13. Common and specific effects of the two major forms of prolactin in the rat testis.
Williams VL; DeGuzman A; Dang H; Kawaminami M; Ho TW; Carter DG; Walker AM
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1795-803. PubMed ID: 17911340
[TBL] [Abstract][Full Text] [Related]
14. Development of a constitutively active mutant form of the prolactin receptor, a member of the cytokine receptor family.
Gourdou I; Gabou L; Paly J; Kermabon AY; Belair L; Djiane J
Mol Endocrinol; 1996 Jan; 10(1):45-56. PubMed ID: 8838144
[TBL] [Abstract][Full Text] [Related]
15. Long term increased expression of the short form 1b prolactin receptor in PC-3 human prostate cancer cells decreases cell growth and migration, and causes multiple changes in gene expression consistent with reduced invasive capacity.
Huang KT; Walker AM
Prostate; 2010 Jan; 70(1):37-47. PubMed ID: 19739126
[TBL] [Abstract][Full Text] [Related]
16. Impact of subdomain D1 of the short form S1b of the human prolactin receptor on its inhibitory action on the function of the long form of the receptor induced by prolactin.
Kang JH; Hassan SA; Zhao P; Tsai-Morris CH; Dufau ML
Biochim Biophys Acta; 2014 Jul; 1840(7):2272-80. PubMed ID: 24735798
[TBL] [Abstract][Full Text] [Related]
17. A molecular mimic of phosphorylated prolactin (S179D PRL) secreted by eukaryotic cells has a conformation with an increased positive surface charge compared to that of unmodified prolactin.
Ueda EK; Soares CR; Bartolini P; DeGuzman A; Lorenson MY; Walker AM
Biochemistry; 2009 Jul; 48(29):6887-97. PubMed ID: 19555049
[TBL] [Abstract][Full Text] [Related]
18. Functional activity of the human prolactin receptor and its ligands.
Lochnan HA; Buteau H; Richards S; Edery M; Kelly PA
Mol Cell Endocrinol; 1995 Oct; 114(1-2):91-9. PubMed ID: 8674856
[TBL] [Abstract][Full Text] [Related]
19. The Nb2 form of prolactin receptor is able to activate a milk protein gene promoter.
Ali S; Edery M; Pellegrini I; Lesueur L; Paly J; Djiane J; Kelly PA
Mol Endocrinol; 1992 Aug; 6(8):1242-8. PubMed ID: 1406702
[TBL] [Abstract][Full Text] [Related]
20. Blockade of estrogen-stimulated proliferation by a constitutively-active prolactin receptor having lower expression in invasive ductal carcinoma.
Huang KT; Tan D; Chen KE; Walker AM
Cancer Lett; 2015 Mar; 358(2):152-160. PubMed ID: 25527452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
